BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.

Related Keywords

Toronto ,Ontario ,Canada ,United States ,Greg Guyer ,Salveen Richter ,Alexander Hardy ,Jeff Ajer ,Jessica Fye ,Henry Fuchs ,Akash Tewari ,Traci Mccarty ,Hank Fuchs ,Brian Mueller ,Nasdaq ,Goldman Sachs ,Biomarin Pharmaceutical Inc ,Biomarin Pharmaceutical ,Call Transcript February ,Marin Pharmaceutical ,Biomarin Pharmaceutical Fourth Quarter ,Full Year ,Investor Relations ,Chief Executive Officer ,Executive Vice President ,Chief Financial Officer ,Chief Commercial Officer ,Chief Technical Officer ,Investor Day ,Pediatric Endocrine Society Meeting ,Strong Buy Stocks To Invest ,